Locop, Pilar B.
HRN: 00 56 36 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/21/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
09/21/2023
09/27/2023
IV
4.5gm
Q6
ARF Sec To BA In AE; CAP HR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes